JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


The Journal of Nuclear Medicine Vol. 25 No. 8 870-873
© 1984 by Society of Nuclear Medicine
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by McGregor, C. G. A.
Right arrow Articles by McDougall, I. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by McGregor, C. G. A.
Right arrow Articles by McDougall, I. R.

Technetium-99m Pyrophosphate in Diagnosis of Acute Cardiac Rejection in the Rat with Effect of Cyclosporine: Concise Communication

Christopher G. A. McGregor, Rudolph Hatz, Salim Aziz, Margaret B. Billingham and I. Ross McDougall

Stanford University Medical Center, Stanford, California

Correspondence: For reprints contact: Dr. Christopher G. A. McGregor, Dept. of Cardiovascular Surgery, Stanford University Medical Center, Stanford, CA 94305.

ABSTRACT

Tc-99m pyrophosphate (PPI) uptake has been measured in a rat model of heterotopic heart transplant at 5 days after transplantation. Comparison of tracer uptake, as a ratio between the heterotopic transplanted heart and the recipient's native heart, was made in four groups of animals. Group 1, with transplants between animals of isogeneic strain showed a lower ratio, significantly different from the ratio in Group 2 in which transplants were between nonisogeneic animals. The ratio of uptake after transplantation between nonisogeneic animals treated with 10 mg/kg-day of cyclosporine (Group 3), was not significantly different from Group 1. In contrast, the ratio of uptake between nonisogeneic animals treated with subtherapeutic doses of cyclosporine (Group 4), was not significantly different from Group 2. In Group 1,2, and 3 there was a correlation between the histology of the transplanted hearts, graded 1 to 5 according to the severity of rejection, compared with the uptake of Tc-99m PPI. This agent can therefore be used to diagnose cardiac rejection in a rat model, and the results correlate well with the severity of rejection as assessed histologically.




This article has been cited by other articles:


Home page
Ann. Thorac. Surg.Home page
C. M.R. Satur, D. Doyle, S. Darracott-Cankovic, W. Martin, and D. J. Wheatley
Can technetium 99m pyrophosphate be used to quantify myocardial injury in donor hearts?
Ann. Thorac. Surg., December 1, 1999; 68(6): 2225 - 2230.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 1984 by the Society of Nuclear Medicine.